News

Thermo Fisher Scientific Launches PangenomiX Array to Support Population-Scale Disease Studies and Pharmacogenomics Research

CARLSBAD, Calif.–(BUSINESS WIRE)–Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more diverse representation of the human genome1. To […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of an upsized underwritten public offering of 10,000,000 […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ChemDiv Marks a Milestone as Orionis Biosciences’ Novel Immunotherapy Enters Phase I Clinical Trials

SAN DIEGO, Jan. 3, 2024 /PRNewswire/ — ChemDiv Inc, a leading provider of drug discovery platforms and development solutions, celebrates a significant milestone in collaboration with Orionis Biosciences: the commencement of Phase I clinical trials […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SAN DIEGO, Jan. 2, 2024 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced it has completed […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Neurohacker Collective Announces Free Masterclass For Health Practitioners On Latest Aging Discovery

Clinically Tested Supplement Formulators Present The Science Of Senolytics CARLSBAD, Calif., Jan. 2, 2024 /PRNewswire/ — Neurohacker Collective, a global nutraceutical company dedicated to healthy aging, has announced a physician’s only masterclass about the emerging […]

No Picture
News

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will host a conference call to discuss topline […]